Compound Found in Onions Could Control the Growth of Ovarian Cancer
Ovarian cancer is the fifth most common cause of death among women in the United States. Epithelial ovarian cancer (EOC) is the most common form with only a five-year survival rate around 40 percent. The low survival rate has urged scientists to concentrate on findings more effective treatments for the disease.
Scientific Reports recently published the results of a study on the effect onions have on ovarian cancer. The researchers, from Kumamoto University in Japan, identified a naturally occurring compound in onions — called onionin A or ONA — that had a positive effect on EOC patients.
Using a preclinical model, researchers grew EOC in cells and then introduced ONA. After the researchers administered ONA, they found the EOC growth slowed down and inhibited pro-tumor activities of cells linked with the suppression of the body’s natural anti-tumor response.
With these promising results, the researchers turned to mouse models with active EOC. When researchers administered ONA orally, the mice experienced longer lifespans than untreated mice and also showed reduced development of cancer tumors.
More testing is necessary to assess side effects and develop protocols for testing in human trials. However, the researchers are optimistic that an oral ONA supplement would be helpful alongside traditional cancer treatments, thanks to ONA’s enhancement of anti-cancer drug effects.
Ovarian Cancer Can Qualify You for Social Security Disability Benefits
If treatment or your cancer itself causes you to become unable to work and earn a substantial income, you might be qualified for Social Security disability benefits.
Call the Disability Help Group at 800-800-2009 to speak with a disability advocate and learn about your rights to benefits from the Social Security Administration.